Severity of multisystem inflammatory syndrome in children (MIS-C) in patients with and without mucocutaneous findings
- PMID: 36627110
- DOI: 10.1111/pde.15243
Severity of multisystem inflammatory syndrome in children (MIS-C) in patients with and without mucocutaneous findings
Abstract
Background: There are few studies comparing severity of MIS-C disease with mucocutaneous symptoms, age, race, and ethnicity.
Objective: To describe the mucocutaneous symptoms present on admission and evaluate whether these symptoms are correlated with a more severe MIS-C disease course.
Methods: Retrospective cohort study of hospitalized patients with suspected MIS-C between May 13, 2020 to April 21, 2021.
Results: Of the 66 patients who met the inclusion criteria, 84.8% (56/66) exhibited mucocutaneous findings. The most common mucocutaneous symptoms were rash, conjunctivitis, cracked lips, and sore throat. Children with mucocutaneous symptoms were younger (median 9.8 years) compared to those without (11.4 years), p = .39. The groups had similar proportions of pediatric intensive care unit admission, abnormal cardiology studies, and necessity of pressors. The presence of mucocutaneous findings on admission was associated with a lower troponin level on admission (median 0.08 ng/ml vs. 0.52, p = .003). Black children had higher odds of severe MIS-C compared to White children (odds ratio [95% CI]: 3.30 [1.02, 10.72], p = .047). Children ≥5 years of age had greater odds of severe MIS-C compared to children <5 years of age (odds ratio [95% CI]: 5.43 [1.39, 21.23], p = .02).
Limitations: The sample size was relatively small, there was no dermatologist present on admission, initial diagnostic testing and management varied if patients presented at outside hospitals, and the CDC case definition for MIS-C was highly sensitive.
Conclusion: The presence of mucocutaneous symptoms negatively correlated with troponin levels, but there was no significant association between these symptoms and other markers of cardiac involvement (echocardiogram, ejection fraction, electrocardiogram).
Keywords: COVID-19; MIS-C; mucocutaneous disease; multisystem inflammatory syndrome in children; pediatric dermatology.
© 2023 Wiley Periodicals LLC.
Similar articles
-
Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children.J Am Acad Dermatol. 2021 Feb;84(2):408-414. doi: 10.1016/j.jaad.2020.10.060. Epub 2020 Oct 24. J Am Acad Dermatol. 2021. PMID: 33323343 Free PMC article.
-
Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study.Lancet Child Adolesc Health. 2021 May;5(5):323-331. doi: 10.1016/S2352-4642(21)00050-X. Epub 2021 Mar 10. Lancet Child Adolesc Health. 2021. PMID: 33711293 Free PMC article.
-
Mucocutaneous Manifestations of Multisystem Inflammatory Syndrome in Children During the COVID-19 Pandemic.JAMA Dermatol. 2021 Feb 1;157(2):207-212. doi: 10.1001/jamadermatol.2020.4779. JAMA Dermatol. 2021. PMID: 33295957 Free PMC article.
-
Multisystem Inflammatory Syndrome in Adults: Case Finding Through Systematic Review of Electronic Medical Records.Clin Infect Dis. 2022 Nov 30;75(11):1903-1911. doi: 10.1093/cid/ciac303. Clin Infect Dis. 2022. PMID: 35442436 Free PMC article.
-
Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.World J Pediatr. 2021 Aug;17(4):335-340. doi: 10.1007/s12519-021-00435-y. Epub 2021 May 20. World J Pediatr. 2021. PMID: 34013488 Free PMC article. Review.
Cited by
-
Skin manifestations and related clinical characteristics of multisystem inflammatory syndrome in children: A descriptive retrospective cohort study at Texas Children's Hospital.JAAD Int. 2024 Oct 22;18:122-127. doi: 10.1016/j.jdin.2024.09.009. eCollection 2025 Feb. JAAD Int. 2024. PMID: 39719960 Free PMC article.
References
REFERENCES
-
- Mantovani A, Rinaldi E, Zusi C, Beatrice G, Saccomani MD, Dalbeni A. Coronavirus disease 2019 (COVID-19) in children and/or adolescents: a meta-analysis. Pediatr Res. 2021;89(4):733-737. doi:10.1038/s41390-020-1015-2
-
- Radia T, Williams N, Agrawal P, et al. Multi-system inflammatory syndrome in children & adolescents (MIS-C): a systematic review of clinical features and presentation. Paediatr Respir Rev. 2021;38:51-57. doi:10.1016/j.prrv.2020.08.001
-
- Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607-1608. doi:10.1016/S0140-6736(20)31094-1
-
- Toubiana J, Poirault C, Corsia A, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020;369:m2094. Published 2020 Jun 3. doi:10.1136/bmj.m2094
-
- Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771-1778. doi:10.1016/S0140-6736(20)31103-X
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous